Evidence map›Paper›PMID 41181519›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Generative diffusion model enables quantification of calibration-free arterial spin labeling perfusion magnetic resonance imaging data in an Alzheimer's disease cohort.

Qinyang Shou, Steven Cen, Nan-Kuei Chen, John M Ringman, Hosung Kim, Clifford R Jack, Bret J Borowski, Matthew L Senjem, Arvin Arani, Danny J J Wang and 1 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qinyang ShouLaboratory of Functional MRI Technology (LOFT) Stevens Neuroimaging and Informatics Institute University of Southern California Los Angeles California USA.ORCID https://orcid.org/0000-0002-3343-3895
Steven CenDepartment of Neurology Keck School of Medicine University of Southern California Los Angeles California USA.
Nan-Kuei ChenDepartment of Biomedical Engineering University of Arizona Tucson Arizona USA.
John M RingmanDepartment of Neurology Keck School of Medicine University of Southern California Los Angeles California USA.
Hosung KimLaboratory of Neuro Imaging (LONI) Stevens Neuroimaging and Informatics Institute University of Southern California Los Angeles California USA.
Clifford R JackDepartment of Radiology Mayo Clinic Rochester Minnesota USA.
Bret J BorowskiDepartment of Radiology Mayo Clinic Rochester Minnesota USA.
Matthew L SenjemDepartment of Radiology Mayo Clinic Rochester Minnesota USA.
Arvin AraniDepartment of Radiology Mayo Clinic Rochester Minnesota USA.
Danny J J WangLaboratory of Functional MRI Technology (LOFT) Stevens Neuroimaging and Informatics Institute University of Southern California Los Angeles California USA.ORCID https://orcid.org/0000-0002-0840-7062
and for the Alzheimer's Disease Neuroimaging Initiative

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MICHAEL W WEINER · 2016 to 2026
$226.7M
Regulatory and Human Study Operations (RHSO) Core CU19AG065169 · NIA · UNIVERSITY OF ARIZONA · PI BARNES, CAROL A. · 2021 to 2025
$59.8M
SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
USCADRC Diversity Supplement PachicanoP30AG066530 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HELENA Chang CHUI, ARTHUR W TOGA · 2020 to 2026
$27.8M
Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel DiseaseUH3NS100614 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KASHANI, AMIR H, WANG, DANNY JJ · 2018 to 2020
$4.3M
Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic PopulationU01NS100614 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KASHANI, AMIR H, RINGMAN, JOHN M · 2023 to 2025
$3.9M
Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic PopulationUF1NS100614 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KASHANI, AMIR H, RINGMAN, JOHN M · 2021 to 2021
$2.6M
Imaging Cerebral Small Vessels in Vascular Cognitive Impairment and Dementia (VCID)RF1AG084072 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JIANG, XUEJUAN, SHI, YONGGANG · 2023 to 2023
$2.5M
Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel DiseaseUH2NS100614 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KASHANI, AMIR H, RINGMAN, JOHN M · 2016 to 2017
$2.4M
Multiband ASL for Neurodevelopment StudyR01EB028297 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI WANG, DANNY JJ · 2019 to 2023
$2.2M
Development of High-Speed and Quantitative Neuro MRI Technologies for Challenging Patient PopulationsR01NS102220 · NINDS · UNIVERSITY OF ARIZONA · PI CHEN, NAN-KUEI · 2018 to 2022
$2.1M
Non-invasive MRI mapping of BBB water exchange rate and permeabilityR01NS134712 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Danny JJ WANG · 2024 to 2026
$2.1M
NIA NIH HHS P30 AG066530NIA NIH HHS R01 AG084072NIA NIH HHS RF1 AG084072NIA NIH HHS U01 AG006786NIA NIH HHS U19 AG024904NIA NIH HHS U19 AG065169NIBIB NIH HHS R01 EB028297NIH HHS S10 OD032285NINDS NIH HHS R01 NS102220NINDS NIH HHS R01 NS114382NINDS NIH HHS R01 NS134712NINDS NIH HHS U01 NS100614NINDS NIH HHS UF1 NS100614NINDS NIH HHS UH2 NS100614NINDS NIH HHS UH3 NS100614
6 · The paper itself

Abstract

introductionM0 images were missing in Siemens ASL data in Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset, prohibiting cerebral blood flow (CBF) quantification.

methodsA conditional latent diffusion model was trained and evaluated on in-house datasets, then applied to the Siemens data in ADNI-3. Regional CBF differences by Alzheimer's disease (AD) stages, their accuracy for AD classification, and CBF trajectory slopes were compared between generated data (Siemens) and acquired data (General Electric).

resultsThe diffusion model generated M0 images with high fidelity (SSIM = 0.918 ± 0.023, PSNR = 31.361 ± 2.537) and minimal CBF bias (mean difference is 0.21 ± 1.58 mL/100 g/min). Both generated and acquired CBF showed similar spatial patterns and decreasing trends with AD progression in specific AD-related regions. Generated CBF also improved accuracy in classifying AD stages compared to qualitative perfusion images.

conclusionThis study shows the potential of diffusion models for imputing missing modalities in large-scale studies exploring the use of ASL as a biomarker of AD. Highlights: Using latent diffusion model, we can generate M0 image from control image in arterial spin labeling (ASL) with high fidelity.The generated M0 can be used for cerebral blood flow (CBF) quantification in Alzheimer's Disease Neuroimaging Initiative dataset.The performance of classification between Alzheimer's disease (AD) patients and cognitive normal people is better when using generated CBF maps than using non-quantitative perfusion images.ASL CBF decreases with AD progression in key AD-related brain regions.

Indexed as

Alzheimer's diseasearterial spin labelingdiffusion modelquantification

Identifiers

PMID41181519
PMCPMC12572821

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.